Quadmedicine Seeks Phase 1 Trial Approval for Osteoporosis Patch
Quadmedicine applied to South Korea’s Ministry of Food and Drug Safety on October 29, 2026, for approval to conduct a Phase 1 trial of its osteoporosis treatment TeriQ Patch.
Quadmedicine applied to South Korea’s Ministry of Food and Drug Safety on October 29, 2026, for approval to conduct a Phase 1 trial of its osteoporosis treatment TeriQ Patch.